Why Novavax Shares Soared Today
Shares of Novavax (NASDAQ: NVAX) were soaring 14.9% as of 3 p.m. EDT on Monday. The big jump came after B. Riley FBR analyst Mayank Mamtani boosted his 12-month price target on the biotech stock to $61 per share from $53.
Investors should take analysts' price targets with a grain of salt. However, it's good to understand what influences analysts' thinking.
Image source: Getty Images.
Source Fool.com